Antitumor Activity of Titanocene Y in Xenografted PC3 Tumors in Mice

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|5|2|141-144

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.5, Iss.2, 2008-03, pp. : 141-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antitumor Activity of Oxali-Titanocene Y in Xenografted CAKI-1 Tumors in Mice

By  

Letters in Drug Design & Discovery, Vol. 5, Iss. 8, 2008-12 ,pp. : 489-493

Bentham Science Publishers

Access to resources Recommend Favorite

The Activity of Titanocene T Against Xenografted Caki-1 Tumors

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 5, 2013-06 ,pp. : 375-381

Bentham Science Publishers

Access to resources Recommend Favorite

The Antiangiogenic and Antitumoral Activity of Titanocene Y* In Vivo

By  

Letters in Drug Design & Discovery, Vol. 8, Iss. 4, 2011-05 ,pp. : 302-307

Bentham Science Publishers

Access to resources Recommend Favorite

Nanoparticulate paclitaxel demonstrates antitumor activity in PC3 and Ace-1 aggressive prostate cancer cell lines

By Axiak-Bechtel Sandra   Kumar Senthil   Dank Kristin   Clarkson Nicole   Selting Kim   Bryan Jeffrey   Rosol Thomas   Espinosa Jahna   Decedue Charles  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1609-1615

Springer Publishing Company

Access to resources Recommend Favorite

Ultrasound enhanced antitumor activity of liposomal doxorubicin in mice

By Hagtvet Eirik   Evjen Tove J.   Olsen Dag Rune   Fossheim Sigrid L.   Nilssen Esben A.  

Journal of Drug Targeting, Vol. 19, Iss. 8, 2011-09 ,pp. : 701-708

Informa Healthcare

Access to resources Recommend Favorite